Inhibition of the functional expression of N-methyl-D-aspartate receptors in a stably transformed cell line by cyclosporin A

Biochemical Pharmacology

Volumn 68, Issue 3, 2004, Pages 563-571

  Steinmetz, Ralf Dirk ^a   Firla, Beate ^a   Steinhilber, Dieter ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Ca2+ i; controlled salt solution; CsA; CSS; cyclophillin; cyclosporine A; CyP; dexamethasone; DM; FK506 binding protein; FKBP; IL; interleukin; intracellular calcium concentration; lactate dehydrogenase; LDH; N methyl D aspartate; NMDA; NR

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYCLOSPORIN A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TACROLIMUS;

ARTICLE; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MEMBRANE PERMEABILITY; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; RECEPTOR BINDING;

CELL LINE; CELL LINE, TRANSFORMED; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; RECEPTORS, N-METHYL-D-ASPARTATE; TACROLIMUS; TIME FACTORS;

EID: 3042739256     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2004.04.017     Document Type: Article

References (46)

1. Ho S., Clipstone N., Timmermann L., Northrop J., Graef I., Fiorentino D., et al. The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol. 80(3 Pt 2):1996;S40-S45
2. Harding M.W., Handschumacher R.E. Cyclophilin, a primary molecular target for cyclosporine. Structural and functional implications. Transplantation. 46(2 Suppl):1988;29S-35S
3. Handschumacher R.E., Harding M.W., Rice J., Drugge R.J., Speicher D.W. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science. 226(4674):1984;544-547
4. Price E.R., Zydowsky L.D., Jin M.J., Baker C.H., McKeon F.D., Walsh C.T. Human cyclophilin B: a second cyclophilin gene encodes a peptidyl-prolyl isomerase with a signal sequence. Proc Natl Acad Sci USA. 88(5):1991;1903-1907
5. Connern C.P., Halestrap A.P. Purification and N-terminal sequencing of peptidyl-prolyl cis-trans-isomerase from rat liver mitochondrial matrix reveals the existence of a distinct mitochondrial cyclophilin. Biochem J. 284(Pt 2):1992;381-385
6. Tocci M.J., Matkovich D.A., Collier K.A., Kwok P., Dumont F., Lin S., et al. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol. 143(2):1989;718-726
7. Harding M.W., Galat A., Uehling D.E., Schreiber S.L. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature. 341(6244):1989;758-760
8. Liu J., Farmer J.D. Jr., Lane W.S., Friedman J., Weissman I., Schreiber S.L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 66(4):1991;807-815
9. Tong G., Shepherd D., Jahr C.E. Synaptic desensitization of NMDA receptors by calcineurin. Science. 267(5203):1995;1510-1512
10. Schinder A.F., Olson E.C., Spitzer N.C., Montal M. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J Neurosci. 16(19):1996;6125-6133
11. Friberg H., Ferrand-Drake M., Bengtsson F., Halestrap A.P., Wieloch T., Cyclosporin A. Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. J Neurosci. 18(14):1998;5151-5159
12. Ankarcrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., et al. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron. 15(4):1995;961-973
13. Nicotera P., Ankarcrona M., Bonfoco E., Orrenius S., Lipton S.A. Neuronal necrosis and apoptosis: two distinct events induced by exposure to glutamate or oxidative stress. Adv Neurol. 72:1997;95-101
14. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., Lipton S.A. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA. 92(16):1995;7162-7166
15. Leist M., Nicotera P. Apoptosis versus necrosis: the shape of neuronal cell death. Results Probl Cell Differ. 24:1998;105-135
16. Stout A.K., Raphael H.M., Kanterewicz B.I., Klann E., Reynolds I.J. Glutamate-induced neuron death requires mitochondrial calcium uptake. Nat Neurosci. 1(5):1998;366-373
17. Leist M., Nicotera P. Calcium and neuronal death. Rev Physiol Biochem Pharmacol. 132:1998;79-125
18. Broekemeier K.M., Dempsey M.E., Pfeiffer D.R. Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J Biol Chem. 264(14):1989;7826-7830
19. Bernardi P., Broekemeier K.M., Pfeiffer D.R. Recent progress on regulation of the mitochondrial permeability transition pore a cyclosporin-sensitive pore in the inner mitochondrial membrane. J Bioenerg Biomembr. 26(5):1994;509-517
20. Nieminen A.L., Petrie T.G., Lemasters J.J., Selman W.R. Cyclosporin A delays mitochondrial depolarization induced by N-methyl-D-aspartate in cortical neurons: evidence of the mitochondrial permeability transition. Neuroscience. 75(4):1996;993-997
21. Griffiths E.J., Halestrap A.P. Further evidence that cyclosporin A protects mitochondria from calcium overload by inhibiting a matrix peptidyl-prolyl cis-trans isomerase. Implications for the immunosuppressive and toxic effects of cyclosporin. Biochem J. 274(Pt 2):1991;611-614
22. Nicolli A., Basso E., Petronilli V., Wenger R.M., Bernardi P. Interactions of cyclophilin with the mitochondrial inner membrane and regulation of the permeability transition pore, and cyclosporin A-sensitive channel. J Biol Chem. 271(4):1996;2185-2192
23. Petronilli V., Nicolli A., Costantini P., Colonna R., Bernardi P. Regulation of the permeability transition pore, a voltage-dependent mitochondrial channel inhibited by cyclosporin A. Biochim Biophys Acta. 1187(2):1994;255-259
24. Steinmetz R.D., Fava E., Nicotera P., Steinhilber D. A simple cell line based in vitro test system for N-methyl-D-aspartate (NMDA) receptor ligands. J Neurosci Methods. 113(1):2002;99-110
25. Leist M., Single B., Castoldi A.F., Kuhnle S., Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med. 185(8):1997;1481-1486
26. Grynkiewicz G., Poenie M., Tsien R.Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 260(6):1985;3440-3450
27. Ehrenberg B., Loew L.M. Absolute spectroscopic determination of cross-membrane potential. J Fluorescence. 3:1993;265
28. Manev H., Favaron M., Candeo P., Fadda E., Lipartiti M., Milani D. Macrolide antibiotics protect neurons in culture against the N-methyl-D-aspartate (NMDA) receptor-mediated toxicity of glutamate. Brain Res. 624(1/2):1993;331-335
29. Dawson T.M., Steiner J.P., Dawson V.L., Dinerman J.L., Uhl G.R., Snyder S.H. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc Natl Acad Sci USA. 90(21):1993;9808-9812
30. McIlhinney R.A., Molnar E., Atack J.R., Whiting P.J. Cell surface expression of the human N-methyl-D-aspartate receptor subunit 1a requires the co-expression of the NR2A subunit in transfected cells. Neuroscience. 70(4):1996;989-997
31. Ruiz F., Alvarez G., Ramos M., Hernandez M., Bogonez E., Satrustegui J. Cyclosporin A targets involved in protection against glutamate excitotoxicity. Eur J Pharmacol. 404(1/2):2000;29-39
32. Ankarcrona M., Dypbukt J.M., Orrenius S., Nicotera P. Calcineurin and mitochondrial function in glutamate-induced neuronal cell death. FEBS Lett. 394(3):1996;321-324
33. Almawi W.Y., Melemedjian O.K. Clinical and mechanistic differences between FK506 (tacrolimus) and cyclosporin A. Nephrol Dial Transplant. 15(12):2000;1916-1918
34. Rezzani R., Corsetti G., Rodella L., Angoscini P., Lonati C., Bianchi R. Cyclosporine-A treatment inhibits the expression of metabotropic glutamate receptors in rat thymus. Acta Histochem. 105(1):2003;81-87
35. Steiner J.P., Connolly M.A., Valentine H.L., Hamilton G.S., Dawson T.M., Hester L., et al. Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A. Nat Med. 3(4):1997;421-428
36. Hong F., Lee J., Song J.W., Lee S.J., Ahn H., Cho J.J., et al. Cyclosporin A blocks muscle differentiation by inducing oxidative stress and inhibiting the peptidyl-prolyl-cis-trans isomerase activity of cyclophilin A: cyclophilin A protects myoblasts from cyclosporin A-induced cytotoxicity. FASEB J. 16(12):2002;1633-1635
37. Andreeva L., Heads R., Green C.J. Cyclophilins and their possible role in the stress response. Int J Exp Pathol. 80(6):1999;305-315
38. Hamilton G.S., Steiner J.P. Immunophilins: beyond immunosuppression. J Med Chem. 41(26):1998;5119-5143
39. Gething M.J., Sambrook J. Protein folding in the cell. Nature. 355(6355):1992;33-45
40. Fesik S.W., Gampe R.T. Jr., Holzman T.F., Egan D.A., Edalji R., Luly J.R., et al. Isotope-edited NMR of cyclosporin A bound to cyclophilin: evidence for a trans 9, 10 amide bond. Science. 250(4986):1990;1406-1409
41. Van Duyne G.D., Standaert R.F., Karplus P.A., Schreiber S.L., Clardy J. Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex. Science. 252(5007):1991;839-842
42. Hurtley S.M., Helenius A. Protein oligomerization in the endoplasmic reticulum. Annu Rev Cell Biol. 5:1989;277-307
43. Klausner R.D., Sitia R. Protein degradation in the endoplasmic reticulum. Cell. 62(4):1990;611-614
44. Rose J.K., Doms R.W. Regulation of protein export from the endoplasmic reticulum. Annu Rev Cell Biol. 4:1988;257-288
45. Chen H., Kubo Y., Hoshi T., Heinemann S.H. Cyclosporin A selectively reduces the functional expression of Kir2.1 potassium channels in Xenopus oocytes. FEBS Lett. 422(3):1998;307-310
46. Helekar S.A., Char D., Neff S., Patrick J. Prolyl isomerase requirement for the expression of functional homo-oligomeric ligand-gated ion channels. Neuron. 12(1):1994;179-189